TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2-Reference-Cited by-同舟云学术

TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2

Published:2021-04-28 Issue:6 Volume:25 Page:491-508
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Kaushik Dhriti¹,Bhandari Ranjana²,Kuhad Anurag³

Affiliation:

1. Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Study, Punjab University, Chandigarh India

2. Assistant Professor of Pharmaceutics, University Institute of Pharmaceutical Sciences UGC-Centre of Advanced Study, Panjab University, Chandigarh, India

3. Assistant Professor of Pharmacology, University Institute of Pharmaceutical Sciences UGC-Centre of Advanced Study, Panjab University, Chandigarh, India

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2021.1918103

Reference135 articles.

1. The cytokine storm of COVID-19: a spotlight on prevention and protection

2. COVID-19: consider cytokine storm syndromes and immunosuppression

3. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

4. Nervous system involvement after infection with COVID-19 and other coronaviruses

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Special Issue “The Role of Toll-Like Receptors (TLRs) in Infection and Inflammation 2.0”;International Journal of Molecular Sciences;2024-09-07

2. In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing;PLOS ONE;2024-07-18

3. Interplay of TLR4 and SARS-CoV-2: Unveiling the Complex Mechanisms of Inflammation and Severity in COVID-19 Infections;Journal of Inflammation Research;2024-07

4. In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants;International Journal of Molecular Sciences;2024-05-17

5. Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects;Marine Life Science & Technology;2024-02-21